logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 9
  • 1
    Harte, Brendan
    Director born in May 1965
    Individual (11 offsprings)
    Officer
    2020-01-22 ~ 2023-10-12
    OF - Director → CIF 0
  • 2
    Fox, Erina
    Individual (26 offsprings)
    Officer
    2020-01-22 ~ now
    OF - Secretary → CIF 0
  • 3
    Grove, Harvey Gordon Edwin
    Director born in May 1948
    Individual (7 offsprings)
    Officer
    2019-04-17 ~ 2021-04-08
    OF - Director → CIF 0
    Grove, Harvey Gordon Edwin
    Individual (7 offsprings)
    Officer
    2015-08-21 ~ 2020-01-22
    OF - Secretary → CIF 0
  • 4
    Sorrel, Sarah Anne
    Company Director born in September 1957
    Individual (3 offsprings)
    Officer
    2015-08-21 ~ 2021-04-08
    OF - Director → CIF 0
    Sarah Anne Sorrel
    Born in September 1957
    Individual (3 offsprings)
    Person with significant control
    2016-04-06 ~ 2020-01-22
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
  • 5
    Hollywood, Simon
    Born in January 1980
    Individual (6 offsprings)
    Officer
    2023-10-12 ~ now
    OF - Director → CIF 0
  • 6
    O'boyle, Bryan
    Director born in October 1982
    Individual (3 offsprings)
    Officer
    2020-01-22 ~ 2023-10-12
    OF - Director → CIF 0
  • 7
    Lyons, Emer
    Born in January 1978
    Individual (10 offsprings)
    Officer
    2023-10-12 ~ now
    OF - Director → CIF 0
  • 8
    Gleeson, Michael
    Director born in November 1978
    Individual (21 offsprings)
    Officer
    2020-01-22 ~ 2022-10-21
    OF - Director → CIF 0
  • 9
    ICON@SERVICES LIMITED 16233830
    South County Business Park, Leopardstown, Dublin 18, Ireland
    Active Corporate (1 parent, 12 offsprings)
    Person with significant control
    2020-01-22 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED

Period: 2021-04-19 ~ now
Company number: 09743789 08326602... (more)
Registered names
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED - now 08326602... (more)
Standard Industrial Classification
64209 - Activities Of Other Holding Companies N.e.c.
Brief company account
Cost of Sales
1,267 GBP2024-01-01 ~ 2024-12-31
600 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
1,267 GBP2024-01-01 ~ 2024-12-31
600 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-1,513 GBP2024-01-01 ~ 2024-12-31
-7,977 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
-246 GBP2024-01-01 ~ 2024-12-31
-7,377 GBP2023-01-01 ~ 2023-12-31
Interest Payable/Similar Charges (Finance Costs)
-3,397 GBP2024-01-01 ~ 2024-12-31
Profit/Loss on Ordinary Activities Before Tax
-3,643 GBP2024-01-01 ~ 2024-12-31
5,529,508 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-1,251 GBP2024-01-01 ~ 2024-12-31
5,502,701 GBP2023-01-01 ~ 2023-12-31
Fixed Assets - Investments
780 GBP2024-12-31
780 GBP2023-12-31
Debtors
32,011,726 GBP2024-12-31
32,008,781 GBP2023-12-31
Cash at bank and in hand
141,441 GBP2024-12-31
166,098 GBP2023-12-31
Current Assets
32,153,167 GBP2024-12-31
32,174,879 GBP2023-12-31
Net Current Assets/Liabilities
32,143,028 GBP2024-12-31
32,144,279 GBP2023-12-31
Net Assets/Liabilities
32,143,808 GBP2024-12-31
32,145,059 GBP2023-12-31
Equity
Called up share capital
210 GBP2024-12-31
210 GBP2023-12-31
210 GBP2022-12-31
Retained earnings (accumulated losses)
32,143,598 GBP2024-12-31
32,144,849 GBP2023-12-31
26,642,148 GBP2022-12-31
Equity
32,143,808 GBP2024-12-31
32,145,059 GBP2023-12-31
26,642,358 GBP2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
-1,251 GBP2024-01-01 ~ 2024-12-31
5,502,701 GBP2023-01-01 ~ 2023-12-31
Average number of employees in administration and support functions
22024-01-01 ~ 2024-12-31
22023-01-01 ~ 2023-12-31
Average Number of Employees
22024-01-01 ~ 2024-12-31
32023-01-01 ~ 2023-12-31
Audit Fees/Expenses
2,220 GBP2024-01-01 ~ 2024-12-31
2,100 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
-911 GBP2024-01-01 ~ 2024-12-31
1,300,571 GBP2023-01-01 ~ 2023-12-31
Investments in Subsidiaries
780 GBP2024-12-31
780 GBP2023-12-31
Cost valuation
780 GBP2023-12-31
Amount of corporation tax that is recoverable
1,145 GBP2024-12-31
Accrued Liabilities
10,139 GBP2024-12-31
10,920 GBP2023-12-31
Corporation Tax Payable
19,680 GBP2023-12-31
Par Value of Share
Class 2 ordinary share
12024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
147 shares2024-12-31
147 shares2023-12-31
Par Value of Share
Class 3 ordinary share
12024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
21 shares2024-12-31
21 shares2023-12-31
Par Value of Share
Class 4 ordinary share
12024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
21 shares2024-12-31
21 shares2023-12-31
Number of Shares Issued (Fully Paid)
210 shares2024-12-31
210 shares2023-12-31

Related profiles found in government register
  • ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED
    Info
    MEDPASS GROUP LIMITED - 2021-04-19
    Registered number 09743789
    3rd Floor, North & South Wings 100 Longwater Avenue, Green Park, Reading, Berkshire RG2 6GP
    PRIVATE LIMITED COMPANY incorporated on 2015-08-21 (10 years 9 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-03-15
    CIF 0
  • ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED
    S
    Registered number 09743789
    500, South Oak Way, Green Park, Reading, Berkshire, United Kingdom, RG2 6AD
    Private Company Limited By Shares in England And Wales, England
    CIF 1
  • ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED
    S
    Registered number 09743789
    500, South Oak Way, Green Park, Reading, United Kingdom, RG2 6AD
    Private Company Limited By Shares in England And Wales, England
    CIF 2
child relation
Offspring entities and appointments 2
  • 1
    ICON CLINICAL RESEARCH (U.K.) NO. 4 LIMITED
    - now 03628305 09743789... (more)
    Insolvency (Case 1) Members voluntary liquidation
    Commencement of winding up on 2024-08-19 during the appointment or period of control
    Due to be dissolved on 2025-11-01 during the appointment or period of control
    MEDPASS INTERNATIONAL LIMITED
    - 2021-04-19 03628305 08326602
    1 More London Place, London
    Dissolved Corporate (16 parents)
    Person with significant control
    2016-04-06 ~ dissolved
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Ownership of voting rights - 75% or more OE
  • 2
    ICON CLINICAL RESEARCH (U.K.) NO. 5 LIMITED
    - now 08326602 09743789... (more)
    MEDPASS LIMITED
    - 2021-04-19 08326602
    MEDPASS INTERNATIONAL HOLDINGS LIMITED - 2014-01-10
    3rd Floor, North & South Wings 100 Longwater Avenue, Green Park, Reading, Berkshire, United Kingdom
    Active Corporate (9 parents)
    Person with significant control
    2016-04-06 ~ now
    CIF 2 - Ownership of shares – 75% or more OE
    CIF 2 - Ownership of voting rights - 75% or more OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.